- Home
- PRPO vs ONFO Comparison
PRPO vs ONFO Comparison
Compare PRPO & ONFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPO
- ONFO
- Stock Information
- Founded
- PRPO N/A
- ONFO 2018
- Country
- PRPO United States
- ONFO United States
- Employees
- PRPO N/A
- ONFO N/A
- Industry
- PRPO Biotechnology: Laboratory Analytical Instruments
- ONFO Computer Software: Programming Data Processing
- Sector
- PRPO Industrials
- ONFO Technology
- Exchange
- PRPO Nasdaq
- ONFO Nasdaq
- Market Cap
- PRPO 22.0M
- ONFO 5.0M
- IPO Year
- PRPO N/A
- ONFO 2022
- Fundamental
- Price
- PRPO $17.56
- ONFO $1.14
- Analyst Decision
- PRPO
- ONFO
- Analyst Count
- PRPO 0
- ONFO 0
- Target Price
- PRPO N/A
- ONFO N/A
- AVG Volume (30 Days)
- PRPO 16.8K
- ONFO 1.7M
- Earning Date
- PRPO 11-05-2025
- ONFO 11-14-2025
- Dividend Yield
- PRPO N/A
- ONFO N/A
- EPS Growth
- PRPO N/A
- ONFO N/A
- EPS
- PRPO N/A
- ONFO N/A
- Revenue
- PRPO $21,242,000.00
- ONFO $10,508,728.00
- Revenue This Year
- PRPO N/A
- ONFO N/A
- Revenue Next Year
- PRPO N/A
- ONFO N/A
- P/E Ratio
- PRPO N/A
- ONFO N/A
- Revenue Growth
- PRPO 27.05
- ONFO 78.36
- 52 Week Low
- PRPO $3.90
- ONFO $0.61
- 52 Week High
- PRPO $22.38
- ONFO $1.95
- Technical
- Relative Strength Index (RSI)
- PRPO 53.93
- ONFO 53.55
- Support Level
- PRPO $19.40
- ONFO $1.05
- Resistance Level
- PRPO $22.38
- ONFO $1.95
- Average True Range (ATR)
- PRPO 1.39
- ONFO 0.14
- MACD
- PRPO -0.13
- ONFO 0.02
- Stochastic Oscillator
- PRPO 40.46
- ONFO 21.08
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
About ONFO Onfolio Holdings Inc.
Onfolio Holdings Inc actively manages small online businesses that operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by existing teams or have management teams largely in place. The company operates in two business segments: Business to Business (B2B) and Business to Consumers (B2C). The majority of its revenue is generated from the Business-to-Business (B2B) segment, which includes the results of operations of Eastern Standard, RevenueZen, DDS Rank, SEO Butler, Contentellect, DealPipe, and Onfolio LLC.